Clinical Trial

Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes the characteristics of the exhaled metabolic lipid profile for early identification of people with abnormal blood lipids, verifies the feasibility and accuracy of a new gas detection method for screening abnormal blood lipids, and explores a simple, fast, and non-invasive method for screening abnormal blood lipids.
Trial Details
NCT Number NCT07546162
Lead Sponsor Beijing Anzhen Hospital
Conditions Hyperlipidemia
Enrollment 280 participants
Start Date 2026-04-02
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-22